Also trades as: 4553.T (JPX) · $vol 3M
TWAPF OTC
Towa Pharmaceutical Co., Ltd.
1W: +0.0%
1M: -1.0%
3M: +52.9%
YTD: +52.9%
1Y: +inf%
3Y: +8.7%
5Y: -48.2%
$25.98
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$1.3B
52W Range16.83-26
Volume100
Avg Volume4
Beta-0.09
Dividend$0.51
Analyst Ratings
No analyst coverage
Company Info
CEOItsuro Yoshida
Employees4,923
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2009-10-21
Websitetowayakuhin.co.jp
2-11, Shinbashi-cho
Kadoma 571-8580
JP
Kadoma 571-8580
JP
81 6 6900 9100
About Towa Pharmaceutical Co., Ltd.
Operating in Japan, Towa Pharmaceutical Co., Ltd. and its subsidiaries are engaged in the research, development, production, and sale of prescription drugs, active pharmaceutical ingredients, and intermediates. The company's extensive portfolio addresses critical therapeutic areas such as diabetes, digestive health, neurological conditions, and allergic diseases, alongside offering vitamins, antibiotics, and oncology treatments. With approximately 700 different drug products, Towa Pharmaceutical Co., Ltd. was established in 1951 and is headquartered in Osaka, Japan.
Recent Insider Trades
No insider trades found